Offerpad's Q4 results fell short of analysts' estimates, with disappointing revenue, EBITDA, and EPS. The company's stock is down 1.1% and currently trades at $9.1 per share.
Despite promising growth forecasts, Offerpad Solutions' P/S ratio is significantly lower than most industry peers, which could indicate major risk factors putting downward pressure on its stock. Potential volatility in future revenues could be a concern for investors.
CraCra665
:
I go for the underdog. in most cases. I mean what I feel is right of course. I'm not goin to buy another couch when I have one. that being said ima spread it our but. I'm not gettin in when it's at a peak like that. just me tho.
Offerpad Solutions Stock Forum
• $ABM Industries (ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp (AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight (CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy (CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene (CNC.US)$ : Credit Suisse Upgrades to Outperform from...
• $Beacon Roofing Supply (BECN.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $68
• $HF Sinclair (DINO.US)$ : Goldman Sachs Upgrades to Neutral from Sell - PT $43 (from $32)
• $Freshpet (FRPT.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $136
• $HealthEquity (HQY.US)$ : BTIG Upgrades to Buy from Neutral - PT $85
• $Host Hotels & Resorts (HST.US)$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $20)
• $Masco (MAS.US)$ : JPMorgan...
No comment yet